LRRC8A: A multifaceted regulator in cancer, neurological disorders, metabolic diseases and immune modulation

Leucine-rich repeat containing 8A (LRRC8A) is a member of the LRRC8 family, exhibiting broad expression across various tissues and cells in vertebrates. Like other LRRC8 family members, LRRC8A contributes to the formation of volume-regulated anion channels (VRACs), which are crucial for regulating cell volume and maintaining homeostasis. LRRC8A participates in diverse signaling pathways. Multiple studies have validated the links between LRRC8A dysregulation and neurological disorders, metabolic ailments, and tumors. This review provides a comprehensive overview of the regulatory mechanisms of LRRC8A in these pathologies. The primary goal was to assess the potential of LRRC8A as a therapeutic target for treating diseases and address key unresolved issues.

Authors

Institutions

Publication Details

Journal
Genes & Diseases
Published
2025-07-16
DOI
https://doi.org/10.1016/j.gendis.2025.101773
Citations
1
Primary Topic
interferon and immune responses
Type
article
Field-Weighted Citation Impact
0.80
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

LRRC8A: A multifaceted regulator in cancer, neurological disorders, metabolic diseases and immune modulation

Longjun Yang, Mei Liu, Panpan Lu, Qiang Ding et al.
1 citations
Genes & Diseases
interferon and immune responses
0.80
article

LRRC8A: A multifaceted regulator in cancer, neurological disorders, metabolic diseases and immune modulation

Longjun Yang, Mei Liu, Panpan Lu, Qiang Ding, Xiaoyu Ji
article en
1 citations

Abstract

Leucine-rich repeat containing 8A (LRRC8A) is a member of the LRRC8 family, exhibiting broad expression across various tissues and cells in vertebrates. Like other LRRC8 family members, LRRC8A contributes to the formation of volume-regulated anion channels (VRACs), which are crucial for regulating cell volume and maintaining homeostasis. LRRC8A participates in diverse signaling pathways. Multiple studies have validated the links between LRRC8A dysregulation and neurological disorders, metabolic ailments, and tumors. This review provides a comprehensive overview of the regulatory mechanisms of LRRC8A in these pathologies. The primary goal was to assess the potential of LRRC8A as a therapeutic target for treating diseases and address key unresolved issues.

Genes & DiseasesVol. 13(2)
Tongji Hospital (CN), Huazhong University of Science and Technology (CN)
Openalex Percentile: Top 26%
interferon and immune responses
0.80
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.